Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 1.93 Billion

CAGR (2024-2029)

6.84%

Fastest Growing Segment

Dogs

Largest Market

North America

Market Overview

Global Pet Diabetes Care Market has valued at USD 1.93 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.84% through 2029. The pet diabetes care market is witnessing substantial growth because of evolving trends in pet ownership and the heightened awareness surrounding companion animal health. With an increasing number of households considering pets as integral family members, the demand for specialized healthcare services has surged. One of the significant contributors to the expansion of the pet diabetes care market is the rising prevalence of diabetes among pets, primarily driven by factors such as an aging pet population and a parallel increase in pet obesity. As pets face similar health challenges to their human counterparts, including diabetes, there has been a notable shift towards a more comprehensive approach to pet healthcare. This shift is reflected in the market's response to advancements in veterinary diagnostics, treatment options, and an emphasis on preventive measures. The market is further buoyed by ongoing research and development efforts, which aim to introduce innovative solutions for the effective management of pet diabetes. The increasing humanization of pet healthcare, coupled with a growing understanding of the economic and emotional value associated with pets, contributes to a willingness among pet owners to invest in specialized diabetes care. Regulatory support and the availability of insurance coverage for pet health also play pivotal roles in fostering the growth of this market.

Key Market Drivers

Increasing Pet Ownership

The surge in pet ownership has emerged as a pivotal driver influencing the growth of the pet diabetes care market. As more individuals’ welcome pets into their homes, there is a concomitant rise in the demand for comprehensive and specialized healthcare services. The increased humanization of pets, treating them as integral family members, prompts pet owners to prioritize their furry companions' well-being, including addressing chronic conditions like diabetes. With a larger and more diverse pet population, there is a corresponding uptick in the instances of diabetes among pets. This growing prevalence underscores the need for advanced diagnostics, treatment options, and ongoing care, thereby propelling the pet diabetes care market forward. The heightened awareness among pet owners about the importance of early detection and management of diabetes in pets further amplifies the market's growth trajectory. The bond between pet owners and their animals, coupled with a commitment to providing optimal healthcare, creates a conducive environment for the flourishing pet diabetes care market, where innovations and advancements continue to cater to the evolving needs of this expanding demographic.

Advancements in Veterinary Diagnostics

Advancements in veterinary diagnostics play a pivotal role in steering the growth of the pet diabetes care market. The continuous evolution of diagnostic technologies has significantly improved the ability to detect and monitor diabetes in pets with greater precision and efficiency. Cutting-edge diagnostic tools empower veterinarians to diagnose diabetes at earlier stages, enabling prompt intervention and personalized treatment plans. This timely diagnosis is crucial in managing the progression of the disease and mitigating potential complications. Enhanced diagnostic capabilities also contribute to a more accurate understanding of individual pet health profiles, facilitating tailored therapeutic approaches. As pet owners become more proactive in seeking comprehensive healthcare for their animal companions, the availability of advanced diagnostics aligns with their expectations for high-quality and thorough veterinary care. The integration of sophisticated diagnostic tools not only fosters early detection but also supports ongoing monitoring, fostering a proactive approach to pet diabetes management.

Advancements in Pet Diabetes Treatment

Advancements in pet diabetes treatment are instrumental in propelling the growth of the pet diabetes care market. Ongoing research and development efforts in veterinary medicine have led to the introduction of innovative and more effective treatments for pets grappling with diabetes. These advancements include not only novel pharmaceutical interventions but also breakthroughs in therapeutic techniques and management strategies. Improved treatment options provide veterinarians and pet owners with a broader spectrum of choices, enabling the customization of care based on the unique needs of individual animals. As a result, the overall efficacy and success rates of diabetes management in pets have seen considerable enhancements. This, in turn, instills confidence in pet owners, encouraging them to actively seek professional care and invest in the latest treatments for their diabetic pets. The market benefits from this increased demand for cutting-edge solutions, fostering a dynamic landscape where continuous improvements in pet diabetes treatment contribute significantly to the overall growth and advancement of the pet diabetes care market.

Humanization of Pet Healthcare

The humanization of pet healthcare stands as a prominent catalyst in driving the growth of the pet diabetes care market. As pets increasingly assume integral roles within households, there is a parallel shift in how their healthcare is perceived, resembling the approach taken for human family members. Pet owners, viewing their animals as cherished companions, are more inclined to prioritize their well-being, including the management of chronic conditions like diabetes. The emotional bonds formed with pets drive a desire for comprehensive and specialized healthcare, fostering a market that responds to the evolving expectations of pet owners. The humanization trend manifests in various ways, from increased spending on premium pet foods to a heightened demand for advanced veterinary services, including diabetes care. This shift in attitude has a direct impact on the market, spurring innovations, and the development of products and services that align with the high standards pet owners now set for their pets' healthcare. As a result, the humanization of pet healthcare emerges as a compelling force, steering the growth and shaping the landscape of the pet diabetes care market.


Download Free Sample Report

Key Market Challenges

Cost of Treatment

The cost of treatment stands as a formidable obstacle impeding the growth of the pet diabetes care market. Pet owners, while increasingly recognizing the importance of comprehensive healthcare for their animal companions, often face financial constraints when it comes to managing chronic conditions like diabetes in pets. The expenses associated with veterinary consultations, diagnostic tests, prescription medications, and specialized diets can place a significant burden on pet owners. This financial strain may lead to delayed or suboptimal treatment, hindering effective diabetes management for pets. The high costs involved can also impact the adherence of pet owners to prescribed treatment plans, potentially compromising the overall success of diabetes care. As a result, the affordability and accessibility of pet diabetes care become critical factors influencing the market's growth.

Pet Obesity Epidemic

The pet obesity epidemic poses a substantial impediment to the growth of the pet diabetes care market. Obesity is a well-established risk factor for diabetes in both humans and pets, and the rising prevalence of overweight or obese pets has direct implications for the incidence of diabetes among companion animals. The compounding effect of excessive weight on the development and progression of diabetes not only increases the demand for diabetes care but also makes management more challenging. Pet owners, often unaware of the link between obesity and diabetes, may neglect preventive measures, leading to a higher occurrence of diabetes cases. Furthermore, managing diabetes in overweight pets involves more comprehensive and sustained efforts, including specialized diets and increased veterinary interventions, contributing to the economic burden on pet owners. To address this challenge, the pet healthcare industry needs to focus on preventive measures, such as educational campaigns on proper nutrition and exercise, to curb the obesity epidemic among pets and, consequently, alleviate the strain on the pet diabetes care market.

Key Market Trends

Advanced Diagnostics and Monitoring

Advanced diagnostics and monitoring technologies are poised to play a transformative role in shaping the future growth of the pet diabetes care market. The continuous evolution and refinement of diagnostic tools, particularly those dedicated to monitoring blood glucose levels in pets, are expected to significantly enhance the precision and effectiveness of diabetes management. Real-time data provided by these advanced diagnostics offer pet owners and veterinarians a more comprehensive understanding of a diabetic pet's condition, allowing for timely adjustments to treatment plans. In the coming years, the increased availability and adoption of continuous glucose monitoring systems for pets will empower pet owners to actively participate in monitoring their pets' health, promoting a proactive approach to diabetes care.

Furthermore, the integration of smart technologies and wearable devices designed for pets will likely become more prevalent. These devices can monitor various health parameters, providing a holistic view of a pet's well-being beyond glucose levels alone. This trend aligns with the broader movement towards telemedicine in veterinary care, allowing for remote monitoring and consultations. Pet owners can receive real-time insights into their pets' health status, facilitating early intervention and preventive measures.

The influence of advanced diagnostics extends beyond monitoring to early detection. As diagnostic tools become more sensitive and specific, veterinarians can identify pre-diabetic conditions or early-stage diabetes, enabling proactive interventions that may prevent or delay the onset of full-blown diabetes. This shift towards early detection aligns with the broader paradigm of personalized medicine, tailoring treatment plans based on individual pet health profiles.

Telemedicine and Remote Monitoring

Telemedicine and remote monitoring are poised to be transformative forces in influencing the growth of the pet diabetes care market in the coming years. The adoption of telemedicine in veterinary care, fueled by advancements in technology and increased connectivity, is revolutionizing the way pet owners and veterinarians manage chronic conditions such as diabetes. Telemedicine enables pet owners to remotely consult with veterinarians, discuss treatment plans, and seek guidance on diabetes management strategies. This virtual approach to healthcare not only enhances accessibility but also provides a convenient means for pet owners to receive timely advice without the need for frequent in-person visits.

Remote monitoring, coupled with telemedicine, allows for continuous and real-time tracking of a diabetic pet's vital parameters, including blood glucose levels and other relevant health metrics. Wearable devices and smart monitoring tools can transmit data to veterinarians, offering a comprehensive view of a pet's health status. This proactive monitoring helps detect any deviations from normal values, enabling swift adjustments to treatment plans as needed. For pet owners, the ability to remotely monitor their diabetic pets provides a sense of empowerment and active participation in their pets' healthcare journey.

The influence of telemedicine and remote monitoring extends beyond individual consultations. These technologies facilitate the creation of centralized databases, enabling the collection of anonymized health data from a larger pet population. This aggregated data can contribute to research and the development of more effective treatment protocols for diabetes in pets. Additionally, the accessibility of remote monitoring can be particularly beneficial in rural or underserved areas where access to specialized veterinary care may be limited.

Segmental Insights

Animal Type Insights

Based on the Animal type, Dog, has emerged as the dominant in the Global Pet Diabetes Care Market. The dominance of dogs in the global pet diabetes care market can be attributed to various factors. Dogs are one of the most common and popular companion animals globally, with a large and diverse population. Their prevalence in households and their close relationship with humans contribute to a heightened awareness of their health needs, including the increased recognition of diabetes. Additionally, the similarity between canine and human physiology makes dogs an important model for studying and understanding diabetes, leading to advancements in diagnostic tools and treatment options. The robust veterinary healthcare infrastructure and the willingness of dog owners to invest in advanced healthcare for their pets further solidify the prominence of dogs in the pet diabetes care market. The prevalence of obesity and genetic predispositions to diabetes in certain dog breeds also underscores the significance of diabetes management in this animal type.

Solution Insights

Insulin therapy has emerged as the dominant solution in the global pet diabetes care market, owing to several compelling factors. As a primary and often indispensable treatment for managing diabetes in pets, insulin therapy addresses the underlying deficiency in insulin production or utilization. Its prominence can be attributed to the efficacy and well-established track record of insulin in regulating blood glucose levels in both humans and animals. The adaptability of insulin therapy to different pet species, particularly dogs and cats, contributes to its widespread use. Moreover, advancements in insulin formulations, including long-acting options, have enhanced the convenience and effectiveness of treatment, fostering greater acceptance among pet owners and veterinarians alike. The increasing prevalence of diabetes in pets, particularly in response to the growing pet obesity epidemic, further amplifies the demand for insulin therapy. As pet owners become more proactive in seeking optimal healthcare for their diabetic pets, insulin therapy remains a cornerstone in the comprehensive management of pet diabetes, solidifying its dominant position in the global market.


Download Free Sample Report

Regional Insights

North America currently dominates the global Pet Diabetes Care market due to a combination of factors that collectively contribute to its commanding position. The region boasts a large and pet-centric population, with a high percentage of households having companion animals. This prevalence of pet ownership is coupled with a strong culture of responsible pet care, including regular veterinary check-ups and the management of chronic conditions such as diabetes. Moreover, North America is at the forefront of technological advancements and innovations in veterinary medicine, leading to the development and adoption of cutting-edge diagnostic tools, treatment options, and healthcare practices for pets with diabetes. The well-established veterinary healthcare infrastructure, coupled with the high level of awareness among pet owners, further propels the market. Additionally, the region's robust economy and relatively higher disposable income contribute to an increased willingness among pet owners to invest in advanced and comprehensive healthcare solutions for their diabetic pets. The proactive regulatory environment and the presence of key market players and research institutions focused on pet health also contribute to North America's dominance in shaping the global landscape of Pet Diabetes Care.

Recent Developments

  • In August 2022, ALR Technologies SG Pte. Ltd., a diabetes management company, disclosed that it has obtained manufacturing approval from Infinovo Medical Co., Ltd. This authorization allows the company to initiate the first purchase order for the GluCurve Pet CGM, with an anticipated delivery date set for October 2022. The GluCurve Pet CGM marks a significant milestone as the inaugural and exclusive continuous glucose monitoring system designed specifically for diabetic cats and dogs.
  • In March 2022, TeleVet, Inc., a leading provider of technology solutions for veterinary teams, and Boehringer Ingelheim Animal Health USA Inc., a global innovator in animal health products for pets, horses, and livestock, revealed a strategic collaboration. The partnership aims to introduce cutting-edge technology and services designed to streamline the delivery of optimal patient care in veterinary practices. The overarching goal is to alleviate the overall workload for veterinarians while enhancing the quality of care provided.

Key Market Players

  • Merck & Co., Inc.
  • Zoetis Services LLC
  • Boehringer Ingelheim GmbH
  • i-SENS Inc
  • Becton, Dickinson and Company
  • Trividia Health Inc
  • Allison Medical Inc
  • Ultimed Inc
  • ACON Laboratories Inc
  • AccuBioTech Co., Ltd
  • Taidoc Technology Corp

 

By Animal Type

By Solution

 

By Distribution Channel

By Region

 

  • Dogs
  • Cats
  • Others
  • Insulin Therapy
  • Insulin Delivery Devices
  • Other
  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Pet Diabetes Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Pet Diabetes Care Market, By Animal Type:

o   Dogs

o   Cats

o   Others

  • Pet Diabetes Care Market, By Solution:

o   Insulin Therapy

o   Insulin Delivery Devices

o   Others

  • Pet Diabetes Care Market, By Distribution Channel:

o   Veterinary Hospitals & Clinics

o   Retail Pharmacies

o   Others

  • Pet Diabetes Care Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pet Diabetes Care Market.

Available Customizations:

Global Pet Diabetes Care market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Pet Diabetes Care Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validations

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Impact of COVID-19 on Global Pet Diabetes Care Market

5.    Voice of Customers

6.    Global Pet Diabetes Care Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Animal Type (Dogs, Cats, Others)

6.2.2.    By Solution (Insulin Therapy, Insulin Delivery Devices, other)

6.2.3.    By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, others)

6.2.4.    By Region

6.2.5.    By Company (2023)

6.3.  Market Map

7.    North America Pet Diabetes Care Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Animal Type

7.2.2.    By Solution

7.2.3.    By Distribution Channel

7.2.4.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Pet Diabetes Care Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Animal Type

7.3.1.2.2.           By Solution

7.3.1.2.3.           By Distribution Channel

7.3.2.    Canada Pet Diabetes Care Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Animal Type

7.3.2.2.2.           By Solution

7.3.2.2.3.           By Distribution Channel

7.3.3.    Mexico Pet Diabetes Care Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Animal Type

7.3.3.2.2.           By Solution

7.3.3.2.3.           By Distribution Channel

8.    Europe Pet Diabetes Care Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Animal Type

8.2.2.    By Solution

8.2.3.    By Distribution Channel

8.2.4.    By Country

8.3.  Europe: Country Analysis

8.3.1.    Germany Pet Diabetes Care Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Animal Type

8.3.1.2.2.           By Solution

8.3.1.2.3.           By Distribution Channel

8.3.2.    United Kingdom Pet Diabetes Care Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Animal Type

8.3.2.2.2.           By Solution

8.3.2.2.3.           By Distribution Channel

8.3.3.    Italy Pet Diabetes Care Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecasty

8.3.3.2.1.           By Animal Type

8.3.3.2.2.           By Solution

8.3.3.2.3.           By Distribution Channel

8.3.4.    France Pet Diabetes Care Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Animal Type

8.3.4.2.2.           By Solution

8.3.4.2.3.           By Distribution Channel

8.3.5.    Spain Pet Diabetes Care Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Animal Type

8.3.5.2.2.           By Solution

8.3.5.2.3.           By Distribution Channel

9.    Asia-Pacific Pet Diabetes Care Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Animal Type

9.2.2.    By Solution

9.2.3.    By Distribution Channel

9.2.4.    By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.    China Pet Diabetes Care Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Animal Type

9.3.1.2.2.           By Solution

9.3.1.2.3.           By Distribution Channel

9.3.2.    India Pet Diabetes Care Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Animal Type

9.3.2.2.2.           By Solution

9.3.2.2.3.           By Distribution Channel

9.3.3.    Japan Pet Diabetes Care Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Animal Type

9.3.3.2.2.           By Solution

9.3.3.2.3.           By Distribution Channel

9.3.4.    South Korea Pet Diabetes Care Market Outlook

9.3.4.1.        Market Size & Forecast

9.3.4.1.1.           By Value

9.3.4.2.        Market Share & Forecast

9.3.4.2.1.           By Animal Type

9.3.4.2.2.           By Solution

9.3.4.2.3.           By Distribution Channel

9.3.5.    Australia Pet Diabetes Care Market Outlook

9.3.5.1.        Market Size & Forecast

9.3.5.1.1.           By Value

9.3.5.2.        Market Share & Forecast

9.3.5.2.1.           By Animal Type

9.3.5.2.2.           By Solution

9.3.5.2.3.           By Distribution Channel

10. South America Pet Diabetes Care Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Animal Type

10.2.2. By Solution

10.2.3. By Distribution Channel

10.2.4. By Country

10.3.             South America: Country Analysis

10.3.1. Brazil Pet Diabetes Care Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Animal Type

10.3.1.2.2.         By Solution

10.3.1.2.3.         By Distribution Channel

10.3.2. Argentina Pet Diabetes Care Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Animal Type

10.3.2.2.2.         By Solution

10.3.2.2.3.         By Distribution Channel

10.3.3. Colombia Pet Diabetes Care Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Animal Type

10.3.3.2.2.         By Solution

10.3.3.2.3.         By Distribution Channel

11. Middle East and Africa Pet Diabetes Care Market Outlook

11.1.             Market Size & Forecast        

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Animal Type

11.2.2. By Solution

11.2.3. By Distribution Channel

11.2.4. By Country

11.3.             MEA: Country Analysis

11.3.1. South Africa Pet Diabetes Care Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Animal Type

11.3.1.2.2.         By Solution

11.3.1.2.3.         By Distribution Channel

11.3.2. Saudi Arabia Pet Diabetes Care Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Animal Type

11.3.2.2.2.         By Solution

11.3.2.2.3.         By Distribution Channel

11.3.3. UAE Pet Diabetes Care Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Animal Type

11.3.3.2.2.         By Solution

11.3.3.2.3.         By Distribution Channel

12. Market Dynamics

12.1.             Drivers

12.2.             Challenges

13. Market Trends & Developments

13.1.             Recent Development

13.2.             Mergers & Acquisitions

13.3.             Product Launches

14. Global Pet Diabetes Care Market: SWOT Analysis

15. Porter’s Five Forces Analysis

15.1.             Competition in the Industry

15.2.             Potential of New Entrants

15.3.             Power of Suppliers

15.4.             Power of Customers

15.5.             Threat of Substitute Products

16. Competitive Landscape

16.1.             Merck & Co., Inc.

16.1.1. Business Overview

16.1.2. Service Offerings

16.1.3. Recent Developments

16.1.4. Key Personnel

16.1.5. SWOT Analysis

16.2.             Zoetis Services LLC

16.3.             Boehringer Ingelheim GmbH

16.4.             i-SENS Inc

16.5.             Becton, Dickinson and Company

16.6.             Trividia Health Inc

16.7.             Allison Medical Inc

16.8.             Ultimed Inc

16.9.             ACON Laboratories Inc

16.10.          AccuBioTech Co., Ltd

16.11.          Taidoc Technology Corp

17. Strategic Recommendations

18. About Us & Disclaimer

Figures and Tables

Figure 1: Global Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 2: Global Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 3: Global Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 4: Global Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 5: Global Pet Diabetes Care Market Share, By Region, By Value, 2019-2029F

Figure 6: Global Pet Diabetes Care Market Share, By Company, By Value, 2023

Figure 7: Global Pet Diabetes Care Market Map, By Animal Type, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 8: Global Pet Diabetes Care Market Map, By Solution, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 9: Global Pet Diabetes Care Market Map, By Distribution Channel, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 10: Global Pet Diabetes Care Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 11: North America Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 12: North America Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 13: North America Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 14: North America Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 15: North America Pet Diabetes Care Market Share, By Country, By Value, 2019-2029F

Figure 16: United States Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 17 United States Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 18: United States Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 19: United States Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 20: Canada Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 21: Canada Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 22: Canada Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 23: Canada Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 24: Mexico Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 25: Mexico Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 26: Mexico Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 27: Mexico Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 28: Europe Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 29: Europe Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 30: Europe Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 31: Europe Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 32: Europe Pet Diabetes Care Market Share, By Country, By Value, 2019-2029F

Figure 33: France Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 34: France Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 35: France Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 36: France Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 37: United Kingdom Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 38: United Kingdom Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 39: United Kingdom Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 40: United Kingdom Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 41: Germany Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 42: Germany Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 43: Germany Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 44: Germany Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 45: Italy Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 46: Italy Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 47: Italy Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 48: Italy Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 49: Spain Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 50: Spain Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 51: Spain Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 52: Spain Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 53: Asia Pacific Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 54: Asia Pacific Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 55: Asia Pacific Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 56: Asia Pacific Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 57: Asia Pacific Pet Diabetes Care Market Share, By Country, By Value, 2019-2029F

Figure 58: China Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 59: China Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 60: China Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 61: China Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 62: Japan Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 63: Japan Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 64: Japan Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 65: Japan Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 66: India Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 67: India Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 68: India Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 69: India Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 70: Australia Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 71: Australia Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 72: Australia Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 73: Australia Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 74: South Korea Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 75: South Korea Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 76: South Korea Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 77: South Korea Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 78: South America Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 79: South America Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 80: South America Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 81: South America Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 82: South America Pet Diabetes Care Market Share, By Country, By Value, 2019-2029F

Figure 83: Brazil Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 84: Brazil Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 85: Brazil Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 86: Brazil Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 87: Argentina Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 88: Argentina Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 89: Argentina Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 90: Argentina Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 91: Colombia Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 92: Colombia Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 93: Colombia Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 94: Colombia Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 95: Middle East & Africa Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 96: Middle East & Africa Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 97: Middle East & Africa Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 98: Middle East & Africa Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 99: Middle East & Africa Pet Diabetes Care Market Share, By Country, By Value, 2019-2029F

Figure 100: Saudi Arabia Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 101: Saudi Arabia Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 102: Saudi Arabia Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 103: Saudi Arabia Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 104: UAE Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 105: UAE Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 106: UAE Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 107: UAE Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Figure 108: South Africa Pet Diabetes Care Market Size, By Value (USD Billion), 2019-2029F

Figure 109: South Africa Pet Diabetes Care Market Share, By Animal Type, By Value, 2019-2029F

Figure 110: South Africa Pet Diabetes Care Market Share, By Solution, By Value, 2019-2029F

Figure 111: South Africa Pet Diabetes Care Market Share, By Distribution Channel, By Value, 2019-2029F

Frequently asked questions

down-arrow

The market size of the Global Pet Diabetes Care Market was estimated to be USD 1.93 Billion in 2023.

down-arrow

Dogs have secured their position as the leading animal type in the Global Pet Diabetes Care Market for several compelling reasons. Firstly, dogs are one of the most widely owned and beloved companion animals globally, contributing to a substantial and diverse patient population. Their proximity to human lifestyles and households makes them more susceptible to health conditions, including diabetes, leading to a heightened awareness of the disease in this animal type.

down-arrow

North America's dominance in the global Pet Diabetes Care market can be attributed to its forefront position in leveraging advanced technology and innovative practices within the veterinary healthcare sector. The region has consistently been a pioneer in adopting cutting-edge diagnostic tools, treatment methodologies, and healthcare solutions for pets. The integration of advanced technology, such as sophisticated continuous glucose monitoring systems and telemedicine applications, enables veterinarians in North America to provide precise and real-time care for pets with diabetes.

down-arrow

Increasing pet ownership & advancements in veterinary diagnostics are the major drivers for the Global Pet Diabetes Care Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Pet Diabetes Care Market to Grow with a CAGR of 6.84% through 2029

Jan, 2024

Increasing pet ownership & advancements in veterinary diagnostics are factors driving the Global Pet Diabetes Care market in the forecast period 2025-2029.